LYMPH-TARGETING FORMULATIONS

The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PHILLIPS, Anthony, HAN, Sifei, LU, Zijun, HONG, Jiwon, STYLES, Ian Kenneth, TREVASKIS, Natalie, LEE, Given, WINDSOR, John, PORTER, Christopher John
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PHILLIPS, Anthony
HAN, Sifei
LU, Zijun
HONG, Jiwon
STYLES, Ian Kenneth
TREVASKIS, Natalie
LEE, Given
WINDSOR, John
PORTER, Christopher John
description The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes. La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022087659A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022087659A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022087659A13</originalsourceid><addsrcrecordid>eNrjZJDxifQN8NANcQxydw3x9HNXcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRgYW5mamlo6GxsSpAgAbYCIk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LYMPH-TARGETING FORMULATIONS</title><source>esp@cenet</source><creator>PHILLIPS, Anthony ; HAN, Sifei ; LU, Zijun ; HONG, Jiwon ; STYLES, Ian Kenneth ; TREVASKIS, Natalie ; LEE, Given ; WINDSOR, John ; PORTER, Christopher John</creator><creatorcontrib>PHILLIPS, Anthony ; HAN, Sifei ; LU, Zijun ; HONG, Jiwon ; STYLES, Ian Kenneth ; TREVASKIS, Natalie ; LEE, Given ; WINDSOR, John ; PORTER, Christopher John</creatorcontrib><description>The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes. La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220505&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022087659A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220505&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022087659A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PHILLIPS, Anthony</creatorcontrib><creatorcontrib>HAN, Sifei</creatorcontrib><creatorcontrib>LU, Zijun</creatorcontrib><creatorcontrib>HONG, Jiwon</creatorcontrib><creatorcontrib>STYLES, Ian Kenneth</creatorcontrib><creatorcontrib>TREVASKIS, Natalie</creatorcontrib><creatorcontrib>LEE, Given</creatorcontrib><creatorcontrib>WINDSOR, John</creatorcontrib><creatorcontrib>PORTER, Christopher John</creatorcontrib><title>LYMPH-TARGETING FORMULATIONS</title><description>The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes. La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDxifQN8NANcQxydw3x9HNXcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRgYW5mamlo6GxsSpAgAbYCIk</recordid><startdate>20220505</startdate><enddate>20220505</enddate><creator>PHILLIPS, Anthony</creator><creator>HAN, Sifei</creator><creator>LU, Zijun</creator><creator>HONG, Jiwon</creator><creator>STYLES, Ian Kenneth</creator><creator>TREVASKIS, Natalie</creator><creator>LEE, Given</creator><creator>WINDSOR, John</creator><creator>PORTER, Christopher John</creator><scope>EVB</scope></search><sort><creationdate>20220505</creationdate><title>LYMPH-TARGETING FORMULATIONS</title><author>PHILLIPS, Anthony ; HAN, Sifei ; LU, Zijun ; HONG, Jiwon ; STYLES, Ian Kenneth ; TREVASKIS, Natalie ; LEE, Given ; WINDSOR, John ; PORTER, Christopher John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022087659A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PHILLIPS, Anthony</creatorcontrib><creatorcontrib>HAN, Sifei</creatorcontrib><creatorcontrib>LU, Zijun</creatorcontrib><creatorcontrib>HONG, Jiwon</creatorcontrib><creatorcontrib>STYLES, Ian Kenneth</creatorcontrib><creatorcontrib>TREVASKIS, Natalie</creatorcontrib><creatorcontrib>LEE, Given</creatorcontrib><creatorcontrib>WINDSOR, John</creatorcontrib><creatorcontrib>PORTER, Christopher John</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PHILLIPS, Anthony</au><au>HAN, Sifei</au><au>LU, Zijun</au><au>HONG, Jiwon</au><au>STYLES, Ian Kenneth</au><au>TREVASKIS, Natalie</au><au>LEE, Given</au><au>WINDSOR, John</au><au>PORTER, Christopher John</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LYMPH-TARGETING FORMULATIONS</title><date>2022-05-05</date><risdate>2022</risdate><abstract>The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes. La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022087659A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title LYMPH-TARGETING FORMULATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A19%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PHILLIPS,%20Anthony&rft.date=2022-05-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022087659A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true